- Aurora Cannabis (TSX:ACB), a global cannabis stock, is releasing its first German-cultivated dried flower product under the IndiMed brand on January 27
- The strain, Island Sweet Skunk, is a hand-harvested sativa offering 20 per cent THC and over 1 per cent CBD
- Aurora is a global cannabis company serving both the medical and consumer markets across Canada, Europe, Australia and South America
- Aurora Cannabis stock has added 1.45 per cent year-over-year but remains down by 98.21 per cent since 2020
Aurora Cannabis (TSX:ACB), a global cannabis stock, is releasing its first German-cultivated dried flower product under the IndiMed brand on January 27.
The strain in question, Island Sweet Skunk, is a hand-harvested sativa offering 20 per cent THC and over 1 per cent CBD backed by laboratory purity and active ingredient content testing. The company will manufacture the product at its EU-GMP facility in Leuna, Germany.
According to Thursday’s news release, management is confident in its vast European regulatory and manufacturing experience (slide 6) giving it an edge in the German market, fortifying its position as the world’s largest medical cannabis company operating in nationally legal markets.
Leadership insights
“Aurora is proud to deliver to the rapidly growing German market our first domestically produced medical cannabis product – a significant step forward since Germany’s move to decriminalize cannabis earlier this year,” Michael Simon, interim president of Aurora Europe, said in a statement. “As one of three facilities licensed to cultivate in Germany, we are uniquely positioned to offer domestic product from our EU-GMP facility in Leuna, Germany, which operates within Aurora’s global manufacturing network. It is through our expertise in cultivation and deep commitment to science and innovation that we introduce IndiMed to the German patients.”
About Aurora Cannabis
Aurora is a global cannabis company serving both the medical and consumer markets across Canada, Europe, Australia and South America. Its brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being, Greybeard, MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co., Pedanios, IndiMed and CraftPlant.
Aurora Cannabis stock (TSX:ACB) is up by 0.54 per cent trading at C$5.58 per share as of 9:34 am ET. The stock has added 1.45 per cent year-over-year but remains down by 98.21 per cent since 2020.
Join the discussion: Find out what everybody’s saying about this cannabis stock’s expansion in Germany on the Aurora Cannabis Inc. Bullboard and check out Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top photo of an Aurora Cannabis grow room: Aurora Cannabis)